Abstract
ObjectivesTo assess the efficacy and safety of onabotulinumtoxinA for treatment of primary new daily persistent headache (NDPH) and compare its efficacy in NDPH to transformed chronic migraine (CM).MethodsOpen label study...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
